Safety of blood supply in the Caribbean countries: Role of screening blood donors for markers of hepatitis B and C viruses

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 2, 2005, Pages

  Cruz, Jose R ^a   Pérez Rosales, Maria Dolores ^a   Zicker, Fabio ^a   Schmunis, Gabriel A ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Blood donors; Blood transfusion safety; Caribbean countries; Hepatitis B virus; Hepatitis C virus

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CENTRAL AMERICA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION; INFECTION RISK; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SEROLOGY; TORQUE TENO VIRUS;

BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD TRANSFUSION; CARIBBEAN REGION; DISEASE TRANSMISSION, HORIZONTAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; VIREMIA;

EID: 32044433757     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)80038-1     Document Type: Article

References (38)

1. Aach R.D., Stevens C.E., Hollinger F.B., Mosley J.W., Petersen D.A., and Taylor P.E. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assays N Engl J Med 325 1991 1325 1329
2. Allain J.-P. Transfusions risks of yesterday and today Trans Clin Biol 10 2003 1 5
3. Alvarez M., Oyonarte S., Rodriguez P.M., and Hernandez J.M. Estimated risk of transfusion-transmitted viral infections in Spain Transfusion 42 2002 966 972
4. Barrera J.M., Francis B., Ercilla G., Nelles M., Achord D., and Darner J. Improved detection of anti-HCV in post transfusion hepatitis by a third generation ELISA Vox Sang 68 1995 15 18
5. Busch M.P. Should HBV DNA NAT replace HBsAg and/or anti-BHc screening of blood donors? Transf Clin Biol 11 2004 26 32
6. CAREC (Caribbean Epidemiology Center) Report of the Regional Meeting on Blood Banking November 19-21, 1997
7. Chiavetta J.A., Escobar M., Newman A., He Y., Driezen P., and Deeks S. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada,1990-2000 CMAJ 69 2003 767 773
8. Courouce A.M., and Pillonel J. Transfusion-transmitted viral infections N Engl J Med 335 1996 1609 1610
9. Courouce A.M., Le Marrec N., Girault A., Ducamp S., and Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays Transfusion 34 1994 790
10. Cruz J.R. Seeking a safer blood supply Lancet 365 2005 1463 1464
11. de Alarcon P., Benjamin R., Dugdale M., Kessler C., Shopnick R., and Smith P. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies Transfusion 45 2005 1362 1372
12. Fang C.T., Field S.P., Busch M.P., and Heyns Adu P. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield ofnucleic acid Vox Sang 85 2003 9 19
13. Gilstad C.W. Anaphylactic transfusion reactions Curr Opin Hematol 10 2003 419 423
14. Henning H., Schlenke P., Kirschner H., Bauer I., Schulte-Kellinghaus B., and Bluda H. Evaluation of a newly developed microplate enzyme immunoassay of HCV antibodies J Virol Methods 84 2000 181 190
15. Hohenhaus A.E. Transfusion issues in the cancer patient Clin Tech Small Anim Pract 18 2003 135 138
16. Jutkowitz A. Blood transfusion in the perioperative period Clin Tech Small Anim Pract 19 2004 75 82
17. Kitson-Piggott W. Report on the blood safety initiative 2002 CAREC
18. Koerner K., Cardoso M., Dengler T., Kerowgan M., and Kubanek B. Estimated risk of transmission of hepatitis C virus by blood transfusion Vox Sang 74 1998 213 216
19. Madjdpour C., and Spahn D.R. Allogeneic red blood cell transfusions: efficacy, alternatives and indications Br J Anaesth 95 2005 33 42
20. Marcucci C., Madjdpour C., and Spahn D.R. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index Br Med Bull 70 2004 15 28
21. Napolitano L.M., and Corwin H.L. Efficacy of red blood cell transfusion in the critically ill Crit Care Clin 20 2004 255 268
22. THS/EV-2005/0051 PAHO (Pan American Health Organization) Transfusion medicine in the Caribbean and Latin American countries, 2000-2003 2005
23. Phelps R., Robbins K., Liberti T., Machuca A., Leparc G., and Chamberland M. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor Transfusion 44 2004 929 933
24. Robillard P., Chan P., and Kleinman S. Hemovigilance for improvement of blood safety Transfusion Apheresis Sci 31 2004 95 98
25. Sarkodie F., Adarkwa M., Adu-Sarkodie Y., Candotti D., Acheampong J.W., and Allain J.-P. Screening for viral markers in volunteer and replacement blood donors in South Africa Vox Sang 80 2001 142 147
26. Schmunis G.A., and Cruz J.R. The safety of blood supply in Latin America Clin Microbiol Rev 18 2005 12 29
27. Schmunis G.A., Zicker F., Pinheiro F., and Brandling-Bennett D. Risk of transfusion transmitted infectious diseases in Central and South America Emerg Infect Dis 4 1998 5 11
28. Schmunis G., Zicker F., Del Pozo A., and Segura E. Blood transmitted infectious diseases: Argentina 1995-1997 Transfusion 40 2000 1948 1953
29. Schreiber G.B., Busch M.P., Kleinman S.H., and Korelitz J.J. The risk of transfusion-transmitted viral infections N Engl J Med 334 1996 1685 1690
30. Snyder E.L., and Dodd R.Y. Reducing the risk of blood transfusion Hematology (Am Soc Hematol Educ Program) 2001 433 442
31. Soldan K., Barbara J.A.J., Ramsey M.E., and Hall A.J. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply inEngland, 1993-2001 Vox Sang 84 2003 274 286
32. Tawk H.M., Vickery K., Bisset L., Kai Lo S., Cossart Y.E. Infection in Endoscopy Study Group The significance of transfusion in the past as a risk for current hepatitis B and hepatitis C infection: a study in endoscopy patients Transfusion 45 2005 807 813
33. GAO/PEMED-97-1 US General Accounting Office Report to the ranking Minority Member Committee on Commerce, House of Representatives. Blood supply. FDA oversight and remaining issues of safety 1997
34. Uyttendaele S., Claeys H., Mertens W., Verhaert H., and Vermylen C. Evaluation of third generation screening and confirmatory assays for HCV antibodies Vox Sang 66 1994 122 129
35. Vrielink H., Reesink P.J., van den Burg P.J.M., Zaaijer H.I., Cuypers H.T.M., and Lelie P.N. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients Transfusion 37 1997 845 849
36. Weber B., Dengler T., Berger A., Doerr H.W., and Rabenau H. Evalaution of two new automated assays for hepatitis B surface antigen (HBsAg) detection: IMMULITE HBsAg andIMMULITE 2000 HBsAg J Clin Microbiol 41 2003 135 143
37. Report 2, Geneva, WHO/BCT/BTS/01 WHO (World Health Organization) Hepatitis C assays: Operational characteristics (phase 1) 2001
38. Report 1, Geneva. WHO/BCT/BTS/01 WHO (World Health Organization) Hepatitis B surface antigen assays: operational characteristics 2001